- Home
- INMB vs TPCS Comparison
INMB vs TPCS Comparison
Compare INMB & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INMB
- TPCS
- Stock Information
- Founded
- INMB 2015
- TPCS 1956
- Country
- INMB United States
- TPCS United States
- Employees
- INMB N/A
- TPCS N/A
- Industry
- INMB Biotechnology: Pharmaceutical Preparations
- TPCS Metal Fabrications
- Sector
- INMB Health Care
- TPCS Industrials
- Exchange
- INMB Nasdaq
- TPCS Nasdaq
- Market Cap
- INMB 53.4M
- TPCS 51.4M
- IPO Year
- INMB 2019
- TPCS N/A
- Fundamental
- Price
- INMB $1.91
- TPCS $5.44
- Analyst Decision
- INMB Buy
- TPCS
- Analyst Count
- INMB 4
- TPCS 0
- Target Price
- INMB $9.53
- TPCS N/A
- AVG Volume (30 Days)
- INMB 822.2K
- TPCS 59.0K
- Earning Date
- INMB 10-30-2025
- TPCS 08-21-2025
- Dividend Yield
- INMB N/A
- TPCS N/A
- EPS Growth
- INMB N/A
- TPCS N/A
- EPS
- INMB N/A
- TPCS N/A
- Revenue
- INMB $50,000.00
- TPCS $33,424,000.00
- Revenue This Year
- INMB $142.83
- TPCS N/A
- Revenue Next Year
- INMB $14,780.90
- TPCS N/A
- P/E Ratio
- INMB N/A
- TPCS N/A
- Revenue Growth
- INMB N/A
- TPCS 3.78
- 52 Week Low
- INMB $1.71
- TPCS $2.05
- 52 Week High
- INMB $11.64
- TPCS $6.25
- Technical
- Relative Strength Index (RSI)
- INMB 38.01
- TPCS 54.95
- Support Level
- INMB $1.71
- TPCS $5.26
- Resistance Level
- INMB $2.12
- TPCS $5.50
- Average True Range (ATR)
- INMB 0.12
- TPCS 0.26
- MACD
- INMB 0.04
- TPCS -0.04
- Stochastic Oscillator
- INMB 45.45
- TPCS 46.53
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune, INBO3, XPro1595, LIVNate, and others.
About TPCS TechPrecision Corporation Common stock
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.